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Background: Values for dietary iron bioavailability are required for setting dietary reference 
values. Different approaches have been adopted to produce these values, including predictive 
algorithms, measurements of non-heme iron absorption from meals, and a combined model of 
iron intake, serum ferritin concentration and estimates of physiological iron requirements. 
Objective: To provide a new interactive tool to predict dietary iron bioavailability in 
populations where iron intakes and serum ferritin concentrations have been measured. 
Design: Data for iron intake and serum ferritin (a quantitative marker of body iron stores) 
from three studies, two of which were nationally representative surveys of adults in the UK 
and Ireland, and one a study in elderly men and women, were used to develop a model for the 
prediction of dietary iron absorption at each level of serum ferritin concentration. Individuals 
with raised inflammatory markers or taking supplements that contained iron were excluded. 
Results: Mean iron intakes (mg/d) were 13.6 (SD 5.2), 10.3 (SD 4.1) and 10.9 (SD 3.5), and 
  
 
mean serum ferritin concentrations (µg/L) were 140.7 (SD 113.6), 49.4 µg/L (SD 45.8) and 
 
96.7 µg/L (SD 72.8) in men, pre-menopausal and post-menopausal women, respectively. The 
model predicts that at serum ferritin concentrations of 15, 30 and 60 µg/L respectively, mean 
dietary iron absorption would be 22.3%, 16.3% and 11.6% in men, 27.2%, 17.2% and 10.6% 
in pre-menopausal women, and 18.4%, 12.7% and 10.5% in post-menopausal women. 
Conclusions: An interactive program for calculating dietary iron absorption at any level of 
serum ferritin concentration is presented. Differences in iron status were partly explained by 
  
 
age but also by diet, with meat being a key determinant of serum ferritin concentration. The 
effect of diet was more marked at lower serum ferritin concentrations. The model can be 
applied to any adult population where representative, good quality data on iron intake and 
iron status have been collected. Furthermore, dietary iron bioavailability values can be 
derived for any target level of serum ferritin, thus giving risk managers and public health 
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professionals a flexible and transparent basis upon which to base their dietary 
recommendations. 
 
 
Keywords: iron bioavailability, dietary iron absorption, dietary reference values, serum 
ferritin, iron intake 
 
 
Introduction 
 
The bioavailability of dietary iron can be defined as the proportion (or %) of ingested iron 
that is absorbed and utilised within the body. A value for dietary iron bioavailability 
(sometimes referred to as the bioavailability factor) is required to transform physiological 
requirements (i.e. absorbed iron) into dietary intakes, and hence to derive dietary reference 
values (DRVs), and to develop dietary recommendations and public health policies. Initially, 
bioavailability factors were derived from predictive algorithms based on the intake of heme 
iron and enhancers of non-heme iron absorption (1). This was followed by more complex 
algorithms which included inhibitors as well as enhancers of non-heme iron absorption (2, 3) 
where the magnitude of effect of modifiers of non-heme iron absorption was determined from 
single meal studies. In view of the fact that the effect of enhancers and inhibitors may be 
exaggerated in single meal studies (4), average absorption of non-heme iron from more than 
one meal was used to reflect more closely the whole diet (5, 6). However, these do not reflect 
the diet that is consumed over time, and also an adjustment has to be made to take into 
account the heme content of the diet, with an assumed absorption value. 
 
 
We recently developed a novel predictive model for estimating dietary iron bioavailability 
based on measurements of total iron intake (heme and non-heme iron), serum ferritin (SF) 
concentration and factorial calculations of iron requirements (7). The latter were derived 
using the National Academy of Medicine approach for estimating iron losses (8). Individual 
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data for 495 men and 378 pre-menopausal women were used for a model that estimated the 
prevalence of dietary intakes that were assumed to be insufficient to meet the needs of men 
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and women (separately) based on their daily iron intake and a series of absorption values. The 
prevalence of SF concentrations below selected cut-off values was derived and an estimate of 
dietary iron absorption required to maintain specific SF values was then calculated by 
matching the observed prevalence of insufficiency with the prevalence predicted for the 
series of absorption estimates. It was therefore possible to estimate dietary iron absorption 
(bioavailability) at a population level from the individual measurements of total iron intake 
and SF concentration. In this article, we describe the results of applying the model to other 
studies, and present a refined interactive model that can be used as a tool to predict dietary 
iron bioavailability in populations where iron intakes and serum ferritin concentrations have 
been measured. 
 
 
Subjects and Methods 
 
Data were used from three studies, the National Diet and Nutrition Survey (NDNS), the 
National Adult Nutrition Survey (NANS) and the New Dietary Strategies Addressing the 
Specific Needs of the Elderly Population for Healthy Ageing in Europe study (NU-AGE). 
Briefly, NDNS (9) and NANS (10) were nationally representative samples of adults 
(excluding pregnant and breast-feeding women) in the UK (19-64 years) and Republic of 
Ireland (19 years and older), respectively. The NU-AGE study was a randomised controlled 
multicentre trial of healthy, independent older people (without frailty, heart failure or serious 
chronic illness) aged 65–79 years with the aim of assessing the effects of a one year dietary 
intervention on markers of inflammation and health (11, 12). We used baseline data from the 
UK participants only, as their dietary patterns were likely to be similar to the other UK 
surveys; the data were collected between September 2012 and January 2014. The detailed 
methods for data collection have been previously published (9, 10, 11, 12), but the 
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information pertinent to this article (dietary assessment and analytical methods) are 
summarised below. 
 
 
Dietary intake was assessed using seven-day food diaries in NDNS and NU-AGE and four- 
day semi-weighed food records in NANS. Participants were asked to record detailed 
information on the amount and type of all foods and drinks consumed over consecutive days. 
To ensure accuracy of recording, participants were interviewed or a researcher visited 
participants in their homes to review the food records and clarify any inconsistencies. 
 
 
Height was measured to the nearest 0.1 cm using the Leicester height measure in all three 
studies and weight was measured to the nearest 100g using calibrated scales (Soehnle 
Quantratronic scales, NDNS; Tanita body composition analyzer BC-420MA (NANS): and 
Seca electronic column scales, NU-AGE). 
 
 
Blood samples reached laboratories within five hours of collection and were processed and 
stored at −80°C until required for further analysis. Serum ferritin (SF) was measured either 
using a microparticle enzyme immunoassay assay (IMx, Abbott Laboratories, NDNS), 
automated analyser (RX Daytona, Randox, NANS) or an electrochemiluminescence 
immunoassay (Cobas 6000, Roche Diagnostics, NU-AGE). Hemoglobin concentrations 
were determined using either a Bayer H3 automated analyzer (NDNS), Coulter LH700 series 
analyser (NANS) or Sysmex XN (NU-AGE). 
 
SF is an acute phase reactant, therefore in the presence of infection or inflammation, the 
concentration does not accurately reflect iron stores. C-reactive protein (CRP) and  -1- 
α 
 
 
antichymotrypsin (ACT) are two of the biomarkers used to detect the presence of infection or 
inflammation and hence enable the exclusion of individuals with artificially high SF values 
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(13). Serum CRP (hs-CRP) concentrations were measured using an automated analyser, RX 
Daytona, Randox (NANS) or ProcartaPlex kits (Affimetrix) (NU-AGE) and any participants 
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with a raised hs-CRP (>5 mg/L) were excluded. For the NDNS the acute phase reactant ACT 
was measured. 
 
 
In NANS, 1500 individuals were recruited to the study and hsCRP was measured in 849 
subjects. Those with a CRP < 5 mg/L (n=719) who were not taking supplements containing 
iron (n=656) and in whom SF had been measured (n=650) were included in the analysis. In 
the UK arm of the NU-AGE study 272 participants were recruited. Complete data on all 
relevant parameters were available for 246 participants, but 13 participants (5%) with raised 
hs-CRP levels (>5 mg/L) were subsequently excluded and 37participants were excluded 
because they were taking supplements containing iron; this left 196 subjects whose data were 
included in the current analysis. In the NDNS data we used the same exclusion criteria as for 
the other two studies (i.e. excluded if taking supplements containing iron and/or having raised 
inflammatory markers). This has been described previously (7). 
 
 
Iron absorption was estimated from the measured iron intakes along a scale of assumed iron 
absorption values (1-40%). Requirements for absorbed iron were predicted using the 
Institute of Medicine’s distribution of dietary intake requirements, with values interpolated to 
derive iron absorption requirements for each 0.5th percentile (9). These values were 
compared to each individual’s absorbed iron estimate at each point on the 1-40% scale and 
the average absorption for the population was calculated. Subtracting these values from 100 
gave the estimated percentage of the population who require a higher iron absorption to meet 
their requirements (i.e. the estimated prevalence of inadequate iron intakes). A model was 
created for the prediction of dietary iron absorption at each level of SF concentration using 
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the assumption that the estimated prevalence of inadequate intakes would be equivalent to the 
observed prevalence of iron insufficiency, as defined by SF concentrations. 
 
 
Ethics 
 
Ethical approval for NDNS was granted by The South Thames Multi-Centre Research Ethics 
Committee 
(https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216484/dh_1 
28550.pdf), for NANS by University College Cork Clinical Research Ethics Committee of 
the Cork Teaching Hospitals (ECM 3 (p) 04/11/08), and for NU-AGE by the National 
Research Ethics Committee East of England (12/EE/0109). Written informed consent was 
obtained from all participants. 
 
 
Statistics 
 
In view of the effects of sex and menstrual blood loss in women on iron status, all analyses 
were stratified by sex and by menopausal status. Differences in the characteristics of the 
participants in the three study cohorts were compared using one-way ANOVA. The 
distribution of SF was calculated individually for each sex and menopausal group and the 
cumulative  frequencies calculated. 
 
 
We examined associations between estimated iron intake from meat and SF concentrations. 
Quintiles of intake were calculated and ANCOVA was used to calculate adjusted means and 
evaluate statistical trends with adjustment for age, BMI, total iron intake and study cohort. 
 
 
Statistical analysis was performed using Stata version 14 (StataCorp, College Station, Texas, 
USA) and R version 3.2.3 (14). 
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Results 
A flow chart (Supplemental Figure 1) showing the numbers of participants recruited and 
excluded at different stages of the 3 studies is available as Online Supplemental Material. 
Details of the three studies, including study subjects, exclusion criteria, analytical methods 
and dietary assessment are summarised in Supplemental Table 1. The characteristics of the 
participants from the three studies are presented in Table 1 and individual data are given in 
Supplemental File 1. The % of individuals with acute phase reactant values indicative of 
inflammation or infection (hsCRP >5 mg/L or  -1-ACT >0.65 g/L) were 0% in NDNS, 15% 
α 
 
 
in NANS, and 5% in NU-AGE. These individuals were excluded from the analysis as their 
SF concentration may have been elevated and therefore not reflect iron stores accurately. 
 
 
The combined mean iron intakes were 13.6 (SD 5.2), 10.3 (SD 4.1) and 10.9 (SD 3.5) mg/d 
in men, pre- and post-menopausal women, respectively. For post-menopausal women, the 
mean intake was very close to the Population Reference Intake (PRI) of 11 mg/d, and for men 
it was higher than the PRI of 11 mg/d, but for pre-menopausal women the intake was lower 
than the PRI of 16 mg/d (15). However, all groups had intakes above the Average 
Requirement (6, 7, and 6 mg/d for men, pre- and post-menopausal women respectively). 
 
 
The majority of the participants (95%) were iron sufficient (SF >15 µg/L). Mean SF values 
were 140.7 µg/L (± 113.6), 49.4 µg/L (± 45.8) and 96.7 µg/L (± 72.8) in men, pre- 
menopausal women and post-menopausal women, respectively; the cumulative distributions 
of SF concentrations are shown in Figure 1. There was a significant difference in mean SF 
concentrations between the three cohorts, with higher values reported in the NANS across all 
sex and menopausal status groups. Despite higher SF levels, iron intake was not higher in the 
NANS compared to the other two cohorts although iron intake from meat was significantly 
higher. 
  
 
 
 
181  
 
 
182  
 
 
  
 
 
 
Figure 2 shows the predicted prevalence of inadequate iron intakes at different levels of 
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estimated iron absorption, using combined data from the three cohorts. When iron absorption 
was 18% the predicted prevalence of inadequate iron intakes were 5%, 35% and 3% in men, 
pre-menopausal women and post-menopausal women, respectively. These data reflect the 
capacity of the diet to meet iron requirements and when combined with SF values allow 
prediction of the dietary absorption required to maintain a specific iron status (see 
Supplemental File 2). For example, at SF concentrations below 15 µg/L the mean dietary 
iron absorption ranges from 19% in post-menopausal women to 27% in pre-menopausal 
women, compared to 11-12 % for SF concentrations of 60 µg/L (Figure 3). 
 
 
In both men and women there was a positive association between iron intake from meat and 
SF after adjustment for total iron intake, age and BMI (Figure 4). There was a difference in 
iron intake from meat between extreme quintiles of intake of 4.3 mg for men and 3.0 mg for 
women. SF was 32.0 µg/L (± 11.8) higher in quintile 5 compared to quintile 1 of intake for 
men (P-trend = 0.02) and 14.9 µg/L (± 6.1) higher for women (P-trend = 0.01). 
 
 
The program for calculating dietary iron absorption at any level of SF concentration can be 
found in Supplemental File 2. 
 
 
Discussion 
 
In our model, the differences in iron status between the 3 study population groups were partly 
explained by age (post-menopausal women have a lower iron status than pre-menopausal 
women due to their lower iron requirements) but also by diet i.e. the higher intake of meat in 
the NANS groups was associated with higher SF concentration. When adequate body iron 
stores are present at a SF concentration of 60 µg/L, the efficiency of iron absorption is no 
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longer upregulated (16), and the computed differences in dietary iron absorption were 
minimal, but with a lower SF, the effect of diet became more marked, illustrating the 
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importance of applying iron intake and SF data collected in populations with different dietary 
patterns. In particular, it appears that meat consumption is a key determinant of body iron 
status. 
 
 
Although iron requirements for individuals can be estimated reasonably accurately (15) the 
dietary intake needed to supply this quantity of absorbed iron is notoriously difficult to 
estimate because of the uncertainty about dietary iron absorption. In healthy individuals, the 
key determinants of fractional iron absorption are dietary factors (17) and body iron status 
(18), plus short-term regulation related to previous exposure of the mucosal cells to iron (19). 
However, when reliable measures of total iron intake and body iron status exist, the unknown 
variable (dietary iron absorption) can be computed by taking into account calculated 
physiological requirements. A strength of our study is the use of high quality data for iron 
intake and iron status. Furthermore, individuals with raised inflammatory markers were 
removed from the dataset used to derive the model as they may have had an artificially high 
SF concentration that did not reflect body iron stores accurately. We also excluded 
individuals who had been taking supplements containing iron as it impossible to quantify 
their contribution to total iron intake. 
 
 
There are some limitations that should be considered when using the model. Although the 
three datasets used for this study were obtained from 4/7-day dietary intakes (see 
Supplemental Table 1), participant burden should be considered, particularly for large-scale 
epidemiology studies or surveys. Data collected using other dietary assessment methods, such 
as 24 hr recall or Food Frequency Questionnaire (FFQ) may still be applied to the model, but 
the limitations of these intake methods should be acknowledged in the conclusions. Although 
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we were able to exclude users of supplements containing iron and also individuals with 
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elevated inflammatory markers from the datasets, there was insufficient information available 
to assess whether any individuals were taking prescribed or over-the-counter medicines, or 
had particular medical conditions, that could affect iron absorption or body iron status. 
Individuals with chronic conditions were generally excluded from participation in the studies, 
although the aim was to select a cohort that was representative of the population group. 
Furthermore, evidence for the effect of specific medical conditions and medicines on iron 
absorption and/or status is limited, and a large proportion of the general population routinely 
take some form of medication, therefore excluding these individuals is not practical and 
would result in a very limited dataset. However, it remains important to consider all of these 
potential issues when collecting data for the model and interpreting the results. 
 
 
Although it is not possible to measure iron requirements accurately in large numbers of 
individuals, particularly women of child-bearing age whose requirements are largely dictated 
by the magnitude of menstrual blood loss, population means can be computed, and these are 
what are needed to set DRVs, and to develop dietary guidelines and public health policies. 
When setting DRVs for adults, the National Academy of Medicine (2001) used an iron 
bioavailability value of 18%. This was computed by assuming 10% of dietary iron was heme 
iron, with an absorption of 25%, and that the absorption of the remaining 90% of iron (non- 
heme) was 16.8% in individuals with a SF of 15 µg/L (4). WHO/FAO took variations in the 
properties of the diet into account when proposing bioavailability figures, and set DRVs 
based on 4 different values: 15% and 12% for Western-type diets, depending mainly on the 
level of meat intake, and 10% and 5% for developing countries (20). In Europe, the European 
Food Safety Authority (EFSA) (15) applied the probability model developed by Dainty et al 
(7) to derive values of 16% for men and 18% for pre-menopausal women with a population 
mean SF concentration of 30 µg/L. The UK Committee on Medical Aspects of Food Policy 
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(21) selected 15% absorption as typical in industrialised countries, and the Nordic countries 
(22) also applied an iron absorption value of 15% when setting DRVs. 
 
 
 
The lack of consensus in values for dietary iron absorption reflect, in part, differences in the 
type of diet that is considered representative for the adult population in the country (or group 
of countries) under consideration, but also illustrates differences in the selection and 
interpretation of evidence upon which to base the value. We have further evaluated the model 
developed by Dainty et al (7) using survey data from populations consuming Western-diets 
and the interactive model is provided in Supplemental File 2. Use of this model would 
facilitate harmonisation in deriving values for dietary iron absorption, and thereby reduce 
uncertainty. It can be applied to any adult population where representative, good quality data 
on iron intake and iron status have been collected. Furthermore, dietary iron bioavailability 
values can be derived for any target level of SF, thus giving risk managers and public health 
professionals a flexible and transparent basis upon which to base their dietary 
recommendations. 
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Table 1: Characteristics, iron status and dietary intake of participants, stratified by study, sex and menopausal status
1
 
 
Males Pre-menopausal females Post-menopausal  females 
 
 NANS NDNS NU-AGE P NANS NDNS P NANS NDNS NU-AGE P 
n 336 494 77  197 363  117 158 119  
Age (y) 42.8 (16.4) 42.4 (12.0) 70.2 (3.8) <0.001 34.8 (9.4) 34.9 (7.4) 0.80 62.4 (8.9) 57.5 (4.1) 69.8 (3.9) <0.001 
Weight (kg)
2
 87.1 (13.6) 83.7 (14.1) 82.4 (12.2) 0.001 69.7 (12.1) 67.8 (14.3) 0.13 72.0 (12.7) 71.2 (13.2) 68.7 (10.9) 0.09 
BMI (kg/m
2
)
2
 28.0 (4.0) 27.1 (4.3) 27.0 (3.7) 0.01 25.9 (4.4) 25.9 (5.5) 0.97 28.0 (4.7) 27.7 (5.1) 26.4 (3.7) 0.02 
Hemoglobin (g/dL)
3
 15.2 (1.1) 15.1 (1.1) 14.7 (0.9) <0.001 13.3 (1.1) 13.4 (1.0) 0.69 13.4 (1.0) 13.5 (1.1) 12.9 (3.6) 0.07 
Serum ferritin (ug/L) 172 (135) 119 (92.5) 146 (102) <0.001 57.9 (57.8) 44.7 (37.0) 0.001 116 (90.8) 77.0 (55.3) 104 (67.6) <0.001 
Iron (mg/d) 13.8 (5.7) 13.4 (5.1) 14.3 (3.4) 0.37 11.1 (4.6) 9.8 (3.8) 0.001 10.2 (3.3) 10.9 (3.8) 11.6 (3.1) 0.01 
Iron from meat (mg/d) 2.8 (1.7) 2.6 (1.6) 1.3 (0.8) <0.001 1.8 (1.4) 1.5 (1.1) 0.002 1.7 (1.2) 1.5 (1.1) 1.0 (0.7) <0.001 
1
Values are mean (SD), n=1861. NANS= National Adult Nutrition Survey; NDNS=National Diet and Nutrition Survey; NU-AGE= New dietary 
strategies addressing the specific needs of the elderly population for healthy aging in Europe. 
2,3
Missing data for 
2
n=21 and 
3
n=20 
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Legends for Figures 
 
Figure 1: The cumulative distribution of serum ferritin concentrations for men, pre- 
and post-menopausal women by study. 
Values are the percentage of participants in each group. The number of participants were; 
men n=336, n=494 and n=77, pre-menopausal women n=197 and n=363 and 
■ ■ □ ■ ■ 
 
 
post-menopausal women n=117, n=158 and n=119. Mean (±SD) serum ferritin 
■ ■ □ 
 
values were 140.7 µg/L (± 113.6), 49.4 µg/L (± 45.8) and 96.7 µg/L (± 72.8) in men, pre- 
menopausal women and post-menopausal women, respectively. NANS= National Adult 
Nutrition Survey; NDNS=National Diet and Nutrition Survey; NU-AGE= New dietary 
strategies addressing the specific needs of the elderly population for healthy aging in 
Europe. 
 
Figure 2: The predicted prevalence of inadequate iron intakes at different levels of 
iron absorption in men, pre- and post-menopausal women. 
 
Values for predicted prevalence of inadequate iron intake for dietary absorption values 
ranging from 0 to 40%. 
 
Figure 3: Estimated dietary iron absorption for selected serum ferritin values for 
men, and pre- and post-menopausal women. 
 
Predicted dietary iron absorption (%) for serum ferritin concentrations ranging from <15 
to 100 µg/L. 
 
Figure 4: Adjusted serum ferritin values by quintile of iron intake from meat, 
stratified by sex. 
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Values are adjusted means (SE), means are adjusted for age (y), BMI (kg/m
2
), total iron 
intake (mg/d) and study cohort. Mean ± SD values for iron intake from meat in each 
quintile were as follows; females Q1 = 0.2 ± 0.2, Q2 = 0.8 ± 0.1, Q3 = 1.3 ± 0.1, Q4 = 1.9 
± 0.2, Q5 = 3.2 ± 1.2; males Q1 = 0.6 ± 0.3, Q2 1.5 ± 0.2, Q3 2.3 ± 0.2, Q4 3.1 ± 0.3, Q5 
 
5.0 ± 1.5. P-trend calculated using ANCOVA. 
  
 
 
 
 
  
  
 
 
 
   
  
 
 
 
 
 
  
  
 
 
 
 
 
  
